- Latest News
- Hits: 5303

TALAMBAN, CEBU CITY- As part of the 2016 Central Visayas Health Research and Innovation Conference, communicators including writers, journalists, communication professors, videographers, and bloggers from Cebu met for the first time in a meeting of health research communicators last Thursday at University of San Carlos Talamban Campus.
The meeting aims to gather communicators from the region to form SHARE, an initiative of the Philippine National Health Research System (PNHRS) to reach more stakeholders.
SHARE is a community of health research communicators who believes in the power of communication to share health research stories, advocacies, local and national initiatives. The community will support PNHRS and the Philippine Council for Health Research and Development (PCHRD) in communicating and translating research to benefit health research stakeholders.
During the meeting, Dr. Laurence Garcia, Central Visayas Consortium for Health Research and Development (CVCHRD) Chair, also presented the plan of the region in establishing their network of health research communicators.
Among their planned initiatives are the use of broadcast media and quad media to enable interactive information-sharing, Youtube to communicate challenging health researches, and capacity-building workshops to capacitate members.
“The community of health research communicators [SHARE] will help improve the dissemination of health research results in the country,” Dr. Garcia emphasized.
For communicators who are interested to join SHARE, you may contact Ms. Ladylove Baurile at This email address is being protected from spambots. You need JavaScript enabled to view it. or 837-0031. You can also visit www.healthresearch.ph for more information. ■
Dr. Nelia Cortes-Maramba delivers the Dr. Conrado Dayrit Memorial Lecture during Day 1 of the 1st Philippine Herbal Medicine Summit last 25 October 2016 at the Century Park Hotel, Malate, Manila. |
GUIDELINES
PURPOSE
The Alberto G. Romualdez, Jr. Outstanding Health Research Award (AROHRA) encourages researchers to be sensitive to the scientific and technological requirements of the health delivery system and rewards those whose research have contributed significantly to addressing prevalent health issues.
The Award gives recognition to a research program or project that has demonstrated the link between research and practice through the utilization of research findings in the health delivery system. Given by the Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD) in collaboration with the Department of Health (DOH), the award has two (2) categories: Biomedical Research and Health Services Research.
NOMINATION PROCEDURES
1. What can be nominated
Any health research program or project may be considered for the Award. Work to be nominated may fall under any of two categories: Biomedical Research or Health Services Research.
For Biomedical Research, the program or project must be engaged in generating and/or adapting appropriate health technologies that address specific health problems and emphasize the development of diagnostic tools and techniques, biological (e.g. drugs, vaccines, functional foods, etc.), biomedical devices, and ICT-based healthcare technologies.
For Health Services Research, the program or project must be involved in the organization, administration, operation, utilization and other aspects of health services delivery systems that address the country’s social, political, cultural, and economic conditions.
2. Who can nominate
Any institution; members of the consortium; scientific, technological and professional societies or associations; research institutes; universities and colleges; and individuals may nominate. Self-nomination is not allowed.
3. Who can be nominated and what can be a nominated entry
The award is open to a completed research program or project done by Filipino researcher/s. The nominated entry must be done mainly in the Philippines.
For purposes of this Award, a research program refers to a group of interrelated or complementing research projects that require an interdisciplinary or multidisciplinary approach to meet established goal/s within a specific time frame, while a research project refers to the basic unit in the investigation of specific research problems with predetermined objective/s to be accomplished within a specific time frame.
4. How to nominate
Nominations should be made using the prescribed nomination form. Entries from both consortium member institutions and non-consortium member institutions must be submitted to and endorsed by the Chair of the consortium. Each nomination should include ALL of the following:
a. Write-up on the impact of the project on health delivery,a contextualization of the problem that the project/program seeks to address and a description of the program/project, highlighting how the results were utilized, as well as the benefits derived from their utilization.
b. One copy of each of the technical reports and/or publicationsof the completed projects leading to technology transfer and/or translation to a policy formulation or program intervention.
c. Statement from the technology user(s) and program or project end-userdescribing the contribution of the technology and project or program in improving health delivery.
• After the preliminary screening, the judges may ask for additional supporting documents from the nominees.
5. Schedule of Selection and Awarding
The Award is given every three (3) years.
6. Where to send nominations
a. Nominations should be submitted to the regional consortium secretariat not later the deadline. (Please refer to the attached paper for list of addresses)
b. Endorsed entries by the consortium chair should be submitted to DOST-PCHRD.
INCENTIVES
The Award consists of a cash prize of P 500,000 and a trophy for winners of each category.
DEADLINE OF SUBMISSION
Consortium: February 24, 2017
DOST-PCHRD: March 3, 2017
To download the complete guidelines and the Nomination Form, click HERE.
GUIDELINES
Purpose
The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) recognizes the vital role of the research mentor who selflessly shares knowledge and skills, instills values and attitudes, and inspires those involved in the research process, thereby creating an enabling environment and contributing to capacity-building in research.
The Best Mentor Award is offered biennially to recognize and reward mentors in health research who have built the capacities of researchers in the health sector and, in the process, propelled significant advances in the Philippine National Health Research System’s (PNHRS) thrusts as identified in the National Unified Health Research Agenda (NUHRA).
Objective
The Best Mentor Award recognizes excellence in mentorship that instills passion among researchers, redounding to enhanced relevance and productivity in health research.
Eligibility
A. Who can nominate
The nominating party may be any of the following:
•head of the nominee’s institution or immediate supervisor
•colleague/s
•trainee/s
•student/advisee
Self-nomination is not allowed.
B. Who can be nominated
1. must be a Filipino citizen
2. at least a holder of master’s degree degree
3. actively involved in mentoring researchers/students or colleagues for at least 5 years
4. has a good track record as a researcher in terms of publication, product development or policy formulation
5.professionally involved in health research activities either as a research program/project leader, principal and co-principal investigator, mentor/adviser/trainer, or author/co-author
6. actively involved in health research activities such as conduct of research training and extension work, paper presentations, fund generation, research promotion and networking, research agenda setting, and capacity-building activities
Winners are ineligible for subsequent nominations.
How to nominate
Submit the recommendation form (either personally delivered, by courier, or thru email) for initial screening to the regional consortium secretariat. (Please refer to the attached paper for the list of addresses)
For completed DOST-PCHRD and ASTHRDP scholars, submit entries to DOST-PCHRD for screening and endorsement of the PCHRD Scholar’s Society (PSS).
For the qualified nominees
The requirements below should be submitted within the deadline
1. Five (5) hard copies of the following documents:
1.1. Accomplished curriculum vitae of the nominee using the prescribed format for Best Mentor Award
1.2. A narrative description (1,000-1,500 words) of the nominee’s mentoring activities, accompanied by supporting documents, e.g. photos and other relevant documentation.
1.3. Description of other achievements attained related to health research for the last 5 years, including supporting documents e.g. photocopy of certificates of recognition/awards/honors received by the nominee, which are relevant to the nominee’s eligibility criteria in Section IV.B
2. Cite names of 5 mentees, their achievements in research, and a narrative description of the nominee’s contribution to the success of each mentored research.
Schedule of Selection and Awarding
The award is given every two years.
Announcement of Winners and Prizes
• All qualified nominees will receive certificates of recognition.
• Each Cluster Winner from Luzon, Visayas, Mindanao and National Capital Region will receive a cash prize of P100,000.00 and a plaque of recognition.
• The National Winner will receive an additional cash prize of P200,000.00 and trophy during the PNHRS Week Celebration.
DEADLINE OF SUBMISSION
Consortium: January 13, 2017
DOST-PCHRD: January 20, 2017
To download the complete guidelines and the Recommendation Form, click HERE.
Next Generation Scientist Program by Novartis and University of Basel
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Program Overview
The Next Generation Scientist Program by Novartis and University of Basel is an intensive internship program for talented and motivated research scientists from emerging countries.The 3 month program (1 June to 31 August 2017), hosted at the Novartis research site in Basel, Switzerland, is designed to foster both their scientific and professional development.Guided by Novartis mentors, the interns work on a jointly-agreed upon, precompetitive scientific or clinical research project and also participate in a leadership development program designed to enhance their decision-making and communication skills. Research projects expose selected scientists to state-of-the-art methodologies and leading experts in the fields while ensuring use within their home infrastructure.
Program Benefit
The Novartis and University of Basel Next Generation Scientist Program provides interns an opportunity to enrich their education by:
• working on a research project of interest to their local scientific and clinical communities
• augmenting their scientific capabilities through seminars, journal club, discussion
forums, and various educational courses
• networking and collaborating within the intern group, with their mentors, the greater
Novartis scientific community, and where possible, with other academic collaborators
• supporting their educational goals and scientific career development through mentorship
• certification and accreditation from University of Basel
Research Areas
An internship is possible in any of the broad range of therapeutic areas in which Novartis is involved with, e.g.:
• Oncology
• Neuroscience
• Cardiovascular Disease
• Immunology and Dermatology
• Respiratory
• Ophthalmology
Successful candidates will typically work in drug discovery and clinical research disciplines and departments such as:
• Analytical and Imaging Sciences
• Drug Metabolism and Pharmacokinetics
• Biologics
• Modeling and Computer Simulation
• Biomarker Development
• Synthetic Chemistry
• Technical Drug Development and Formulations
• Epidemiology
• Statistics
• Epigenetics and Genomics
• Clinical Trials
• Safety
• Systems and Computational Biology
Included in the internship
• Scientific/Clinical Research Infrastructure and Training: All necessary equipment, training and operational needs (e.g. computers, supplies and reagents) will be provided by Novartis to support investigation of a jointly agreed-upon, pre-competitive (non-proprietary) scientific question or challenge.
• Travel, Accommodations & Visas: Novartis will provide (1) round-trip economy class airfare, (2) student accommodation for the duration of the project, and (3) application for educational visas to the Swiss authorities on behalf of the selected participants.
• Stipend and Health Insurance: Novartis will provide health insurance and a monthly stipend to cover incidentals and basic living expenses.
• Timelines & Location: The 3 month internship program is offered from 1 June to 31 August 2017 in Basel, Switzerland*.
Application Process
Please apply between 1 – 31 October 2016 online to http://www.novartis.com/careers, enter
the following Job ID: 196275BR and submit the following information in one PDF document
(max. 3 MB):
• CV or résumé
• Letter of recommendation/support from a faculty member
• Letter of motivation and program benefit
• Research question of interest
• Current MSc or PhD research proposal
• Academic transcripts/grade reports
*Projects at other Novartis sites may be considered
Please be informed that we accept online applications only during the above-mentioned dates.
Applications before or after the indicated date as well as incomplete documentation cannot be considered for the internship.
For more information about the Next Generation Scientist internship program please contact
This email address is being protected from spambots. You need JavaScript enabled to view it. or for more information about Novartis, please visit www.novartis.com.
Download Next Generation Scientist Program Flyer and Fact Sheet HERE.